Cytomegalovirus UL103 controls virion and dense body egress

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 5125-5135

  Ahlqvist, Jenny ^a,b   Mocarski, Edward ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRONOVA AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENSE BODY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRION; VIRUS ASSEMBLY; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; HERPESVIRIDAE; HUMAN BODY; HUMANS; VIRAL PROTEINS; VIRION; VIRUS RELEASE;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 79955455495     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01682-10     Document Type: Article

References (58)

1. Abate, D. A., S. Watanabe, and E. S. Mocarski. 2004. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J. Virol. 78:10995-11006.
2. Adamo, J. E., J. Schroer, and T. Shenk. 2004. Human cytomegalovirus TRS1 protein is required for efficient assembly of DNA-containing capsids. J. Virol. 78:10221-10229.
3. AuCoin, D. P., G. B. Smith, C. D. Meiering, and E. S. Mocarski. 2006. Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J. Virol. 80: 8199-8210.
4. Baldick, C. J. Jr., and T. Shenk. 1996. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:6097-6105.
5. Bartz, S. R., and M. A. Vodicka. 1997. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12:337-342.
6. Baxter, M. K., and W. Gibson. 2001. Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third. J. Virol. 75:6865-6873.
7. Bechtel, J. T., and T. Shenk. 2002. Human cytomegalovirus UL47 tegument protein functions after entry and before immediate-early gene expression. J. Virol. 76:1043-1050.
8. Blankenship, C. A., and T. Shenk. 2002. Mutant human cytomegalovirus lacking the immediate-early TRS1 coding region exhibits a late defect. J. Virol. 76:12290-12299.
9. Cepeda, V., M. Esteban, and A. Fraile-Ramos. 2010. Human cytomegalovi-rus final envelopment on membranes containing both trans-Golgi network and endosomal markers. Cell. Microbiol. 12:386-404.
10. Chambers, J., et al. 1999. DNA microarrays of the complex human cyto-megalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73:5757-5766.
11. Chen, D. H., H. Jiang, M. Lee, F. Liu, and Z. H. Zhou. 1999. Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology 260:10-16.
12. Chevillotte, M., et al. 2009. Major tegument protein pp65 of human cyto-megalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J. Virol. 83:2480-2490.
13. Craighead, J. E., R. E. Kanich, and J. D. Almeida. 1972. Nonviral micro-bodies with viral antigenicity produced in cytomegalovirus-infected cells. J. Virol. 10:766-775.
14. Das, S., A. Vasanji, and P. E. Pellett. 2007. Three-dimensional structure of the human cytomegalovirus cytoplasmic virion assembly complex includes a reoriented secretory apparatus. J. Virol. 81:11861-11869.
15. Datta, S., N. Costantino, and D. L. Court. 2006. A set of recombineering plasmids for gram-negative bacteria. Gene 379:109-115.
16. Dijkstra, J. M., W. Fuchs, T. C. Mettenleiter, and B. G. Klupp. 1997. Identification and transcriptional analysis of pseudorabies virus UL6 to UL12 genes. Arch. Virol. 142:17-35.
17. Dunn, W., et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
18. Feng, X., J. Schroer, D. Yu, and T. Shenk. 2006. Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle. J. Virol. 80:8371-8378.
19. Fuchs, W., H. Granzow, R. Klopfleisch, B. G. Klupp, and T. C. Mettenleiter. 2006. The UL4 gene of pseudorabies virus encodes a minor infected-cell protein that is dispensable for virus replication. J. Gen. Virol. 87:2517-2525.
20. Fuchs, W., et al. 2005. The UL7 gene of pseudorabies virus encodes a nonessential structural protein which is involved in virion formation and egress. J. Virol. 79:11291-11299.
21. Fuchs, W., B. G. Klupp, H. Granzow, and T. C. Mettenleiter. 1997. The UL20 gene product of pseudorabies virus functions in virus egress. J. Virol. 71:5639-5646.
22. Hayashi, M. L., C. Blankenship, and T. Shenk. 2000. Human cytomegalo-virus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc. Natl. Acad. Sci. U. S. A. 97:2692-2696.
23. Hensel, G., H. Meyer, S. Gartner, G. Brand, and H. F. Kern. 1995. Nuclear localization of the human cytomegalovirus tegument protein pp150 (ppUL32). J. Gen. Virol. 76:1591-1601.
24. Hensel, G. M., et al. 1996. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J. Gen. Virol. 77:3087-3097.
25. Homman-Loudiyi, M., K. Hultenby, W. Britt, and C. Soderberg-Naucler. 2003. Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-Golgi network 46, and mannosidase II. J. Virol. 77:3191-3203.
26. Hwang, J. S., et al. 2007. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomeg-alovirus. J. Virol. 81:11604-11611.
27. Irmiere, A., and W. Gibson. 1983. Isolation and characterization of a non-infectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology 130:118-133.
28. Krosky, P. M., M. C. Baek, and D. M. Coen. 2003. The human cytomegalo-virus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914.
29. Lorz, K., et al. 2006. Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J. Virol. 80:5423-5434.
30. Marchini, A., H. Liu, and H. Zhu. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878.
31. McGeoch, D. J., F. J. Rixon, and A. J. Davison. 2006. Topics in herpesvirus genomics and evolution. Virus Res. 117:90-104.
32. Mersseman, V., et al. 2008. Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. Med. Microbiol. Immunol. 197:97-107.
33. Milbradt, J., S. Auerochs, and M. Marschall. 2007. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J. Gen. Virol. 88:2642-2650.
34. Mocarski, E. 2007. Comparative analysis of herpesvirus-common proteins, p. 44-58. In A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, and K. Yamanishi (ed.), Human herpesviruses. Biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
35. Mori, Y., et al. 2008. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 9:1728-1742.
36. Muranyi, W., J. Haas, M. Wagner, G. Krohne, and U. H. Koszinowski. 2002. Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science 297:854-857.
37. Potena, L., et al. 2007. Frequent occult infection with cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J. Clin. Microbiol. 45:1804-1810.
38. Revello, M. G., E. Percivalle, A. Di Matteo, F. Morini, and G. Gerna. 1992. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J. Gen. Virol. 73:437- 442.
39. Rixon, F. J., C. Addison, and J. McLauchlan. 1992. Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells. J. Gen. Virol. 73:277-284.
40. Sanchez, V., K. D. Greis, E. Sztul, and W. J. Britt. 2000. Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J. Virol. 74:975-986.
41. Sanchez, V., E. Sztul, and W. J. Britt. 2000. Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endo-plasmic reticulum-Golgi-intermediate compartment. J. Virol. 74:3842-3851.
42. Schierling, K., C. Buser, T. Mertens, and M. Winkler. 2005. Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol. 79:3084-3096.
43. Schmitt, J., and G. M. Keil. 1996. Identification and characterization of the bovine herpesvirus 1 UL7 gene and gene product which are not essential for virus replication in cell culture. J. Virol. 70:1091-1099.
44. Schmolke, S., H. F. Kern, P. Drescher, G. Jahn, and B. Plachter. 1995. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69:5959-5968.
45. Severi, B., M. P. Landini, and E. Govoni. 1988. Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch. Virol. 98:51-64.
46. Silva, M. C., Q. C. Yu, L. Enquist, and T. Shenk. 2003. Human cytomega-lovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J. Virol. 77:10594-10605.
47. Stinski, M., and J. Meier. 2007. Immediate-early CMV gene regulation and function, p. 241-263. In A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, and K. Yamanishi (ed.), Human herpesviruses. Biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
48. Szilagyi, J. F., and C. Cunningham. 1991. Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J. Gen. Virol. 72:661-668.
49. Tandon, R., and E. S. Mocarski. 2008. Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J. Virol. 82:9433-9444.
50. Thomason, L., et al. 2007. Recombineering: genetic engineering in bacteria using homologous recombination. Curr. Protoc. Mol. Biol. 78:1.16.1-1.16.24.
51. Tooze, J., M. Hollinshead, B. Reis, K. Radsak, and H. Kern. 1993. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cister-nae for their envelopes. Eur. J. Cell Biol. 60:163-178.
52. Townsend, L. B., R. V. Devivar, S. R. Turk, M. R. Nassiri, and J. C. Drach. 1995. Design, synthesis, and antiviral activity of certain 2,5,6-trihalo-1-(beta-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 38:4098-4105.
53. Trus, B. L., W. Gibson, N. Cheng, and A. C. Steven. 1999. Capsid structure of simian cytomegalovirus from cryoelectron microscopy: evidence for tegument attachment sites. J. Virol. 73:2181-2192.
54. Underwood, M. R., et al. 1998. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 72:717-725.
55. Upton, J. W., W. J. Kaiser, and E. S. Mocarski. 2010. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7:302-313.
56. Varnum, S. M., et al. 2004. Identification of proteins in human cytomegalo-virus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966.
57. Wolf, D. G., C. T. Courcelle, M. N. Prichard, and E. S. Mocarski. 2001. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc. Natl. Acad. Sci. U. S. A. 98:1895-1900.
58. Yu, D., M. C. Silva, and T. Shenk. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401.